Treatment OutcomeOxamniquineRetrospective StudiesNifurtimoxPrognosisOutcome Assessment (Health Care)Follow-Up StudiesSeverity of Illness IndexSchistosomicidesSulfanilamidesNitroimidazolesProspective StudiesRemission, SpontaneousTime FactorsChagas DiseaseTrypanocidal AgentsRisk FactorsCombined Modality TherapyRecurrencePlasma ExchangeTrypanosoma cruziRandomized Controlled Trials as TopicClinical Trials as TopicSchistosomiasis mansoniChronic DiseasePhysical Therapy ModalitiesPregnancy OutcomeAntiprotozoal AgentsSurvival AnalysisCohort StudiesSurvival RateDrug Therapy, CombinationPredictive Value of TestsAcute DiseaseAntitubercular AgentsQuality of LifeResearch DesignTomography, X-Ray ComputedBrazilInfant, NewbornFatal OutcomeAge FactorsComorbidityPrevalenceDirectly Observed TherapyBiological MarkersCognitive TherapyUnited StatesOutcome and Process Assessment (Health Care)Sensitivity and SpecificityQuestionnairesAntineoplastic AgentsDisease Models, AnimalTreatment FailureNeoplasmsBreast NeoplasmsCross-Sectional StudiesTuberculosis, PulmonaryPatient ComplianceExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-ResistantAntibodies, MonoclonalMutationPregnancyBuprenorphineMultivariate AnalysisKaplan-Meier EstimateOpioid-Related DisordersSubstance-Related DisordersPsychotherapySubstance Abuse Treatment CentersHIV InfectionsLogistic ModelsAlcoholismHospitals, Chronic DiseaseNeoplasm StagingTuberculosisTemperanceAntineoplastic Combined Chemotherapy ProtocolsRisk AssessmentPatient SatisfactionPsychiatric Status Rating ScalesRemission InductionPatient DropoutsImplosive TherapyCocaine-Related DisordersDisease-Free SurvivalPostoperative ComplicationsMethadoneDepressive Disorder, MajorLongitudinal StudiesResidential TreatmentRetreatmentProportional Hazards ModelsRegression AnalysisReproducibility of ResultsAnti-Retroviral AgentsChi-Square DistributionGenotypeCoinfection